Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports
Authors:
- Sarah A. MilgromSMSarah A. Milgrom
- Yago NietoYNYago Nieto
- Chelsea C. PinnixCPChelsea C. Pinnix
- Grace L. SmithGSGrace L. Smith
- Christine F. WoganCWChristine F. Wogan
- Gabriela RondonGRGabriela Rondon
- L. Jeffrey MedeirosLML. Jeffrey Medeiros
- Partow KebriaeiPKPartow Kebriaei
- Bouthaina S. DabajaBouthaina S. Dabaja
Open Access
- 28 July 2016
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 10 (1) , 1-5
Abstract
Patients who undergo allogeneic stem cell transplantation and subsequent radiation therapy uncommonly develop graft-versus-host disease within the irradiated area. We quantified the incidence of this complication, which is a novel contribution to the field. From 2010 to 2014, 1849 patients underwent allogeneic stem cell transplantation, and 41 (2 %) received radiation therapy afterward. Of these, two patients (5 %) developed graft-versus-host disease within the irradiated tissues during or immediately after radiation therapy. The first patient is a 37-year-old white man who had Hodgkin lymphoma; he underwent allogeneic stem cell transplantation from a matched unrelated donor and received radiation therapy for an abdominal and pelvic nodal recurrence. After 28.8 Gy, he developed grade 4 gastrointestinal graft-versus-host disease, refractory to tacrolimus and steroids, but responsive to pentostatin and photopheresis. The other patient is a 24-year-old white man who had acute leukemia; he underwent allogeneic stem cell transplantation from a matched related donor and received craniospinal irradiation for a central nervous system relapse. After 24 cobalt Gy equivalent, he developed severe cutaneous graft-versus-host disease, sharply delineated within the radiation therapy field, which was responsive to tacrolimus and methylprednisolone. We conclude that graft-versus-host disease within irradiated tissues is an uncommon but potentially serious complication that may follow radiation therapy in patients who have undergone allogeneic stem cell transplantation. Clinicians must be aware of this complication and prepared with strategies to mitigate risk. Patients who have undergone allogeneic stem cell transplantation represent a unique population that may offer novel insight into the pathways involved in radiation-related inflammation.Keywords
This publication has 16 references indexed in Scilit:
- Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell ActivationThe Journal of Immunology, 2012
- Risk factors for acute GVHD and survival after hematopoietic cell transplantationBlood, 2012
- The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive ImmunityCancer Research, 2011
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteriaBlood, 2011
- The Tumor-Immune Microenvironment and Response to Radiation TherapyJournal of Mammary Gland Biology and Neoplasia, 2010
- IL-8 and IL-6 bystander signalling in human glioblastoma cells exposed to gamma radiation.2010
- Gamma-irradiation-induced Intercellular Adhesion Molecule-1 (ICAM-1) Expression is Associated with Catalase: Activation of Ap-1 and JNKJournal of Toxicology and Environmental Health, Part A, 2006
- Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cellsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Effect of Irradiation on Cytokine Production, MHC Antigen Expression, and Vaccine Potential of Interleukin-2 and Interferon-γ Gene-Modified Melanoma CellsCellular Immunology, 1996
- Cutaneous chronic graft-versus-host disease localized to the field of total lymphoid irradiation.1996